High-flow nasal cannulae, bronchopulmonary dysplasia and retinopathy of prematurity

Show simple item record

dc.contributor.author Healy, L. I.
dc.contributor.author Corcoran, Paul
dc.contributor.author Murphy, B. P.
dc.date.accessioned 2020-01-14T12:38:37Z
dc.date.available 2020-01-14T12:38:37Z
dc.date.issued 2019-09
dc.identifier.citation Healy, L. I., Corcoran, P. and Murphy, B. P. (2019) 'High-flow nasal cannulae, bronchopulmonary dysplasia and retinopathy of prematurity', Irish Medical Journal, 112(8), P985 (7pp). Available at: http://imj.ie/wp-content/uploads/2019/09/High-flow-Nasal-Cannulae-Bronchopulmonary-Dysplasia.pdf (Accessed: 14 January 2020). en
dc.identifier.volume 112 en
dc.identifier.issued 8 en
dc.identifier.startpage 1 en
dc.identifier.endpage 7 en
dc.identifier.issn 0332-3102
dc.identifier.uri http://hdl.handle.net/10468/9502
dc.description.abstract Aims: To determine if HFNC use was associated with changes in incidence of BPD and ROP. Methods: This retrospective study examined premature infants (<30 weeks GA or <1500g) in a tertiary neonatal unit from 2010-2016. Patients were compared before and after introduction of HFNC. Further analysis of high-risk infants (<28 weeks GA or <750g or ventilated) compared those who received HFNC to those who did not across the whole period. Primary outcomes were incidence of BPD and ROP requiring surgery. Results: Incidence of BPD rose following the introduction of HFNC (82/232 (35.3%) after vs 33/251 (13.1%) before, p<0.001). On multivariate analysis, the chance of developing BPD after HFNC introduction remained higher (OR 4.353, 95% CI2.546-7.443). More infants received surgery for ROP following HFNC introduction (0/214 vs 11/205 (5.4%), p=<0.001). In the second analysis, the rate of BPD was higher in those who received HFNC (90/132 (68.1%) vs 33/153 (21.6%), p<0.001). Receiving HFNC demonstrated higher chance of BPD in multivariate analysis (OR 7.802, 95% CI 4.223-14.423). Rate of ROP surgery was higher in those who received HFNC (0/153 vs 13/134 (9.7%), p<0.001). Conclusions: In this study, use of HFNC was associated with significantly increased risk of adverse outcomes. en
dc.format.mimetype application/pdf en
dc.language.iso en en
dc.publisher Irish Medical Organisation en
dc.relation.uri http://imj.ie/wp-content/uploads/2019/09/High-flow-Nasal-Cannulae-Bronchopulmonary-Dysplasia.pdf
dc.rights © 2019, Irish Medical Journal. All rights reserved. en
dc.subject High-flow nasal cannulae en
dc.subject HFNC en
dc.subject Premature en
dc.subject Neonatal en
dc.subject ROP surgery en
dc.title High-flow nasal cannulae, bronchopulmonary dysplasia and retinopathy of prematurity en
dc.type Article (peer-reviewed) en
dc.internal.authorcontactother Paul Corcoran, Epidemiology & Public Health, University College Cork, Cork, Ireland. +353-21-490-3000 Email: pcorcoran@ucc.ie en
dc.internal.availability Full text available en
dc.date.updated 2020-01-14T12:30:22Z
dc.description.version Published Version en
dc.internal.rssid 499917323
dc.description.status Peer reviewed en
dc.identifier.journaltitle Irish Medical Journal en
dc.internal.copyrightchecked Yes
dc.internal.licenseacceptance Yes en
dc.internal.IRISemailaddress pcorcoran@ucc.ie en
dc.identifier.articleid P985 en

Files in this item

This item appears in the following Collection(s)

Show simple item record

This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement